Reply to Correa et al. Comment on “Rivas et al. Unexpectedly Low Rate of Metastasis and Death Among Patients Treated for Uveal Melanoma with Brachytherapy, Vitrectomy, and Silicone Oil. Cancers 2025, 17, 2683”

Key Points

• To respond to critiques regarding the treatment outcomes of uveal melanoma patients.
• Engaged with comments from the Collaborative Ocular Oncology Group.
• Reviewed existing research on treatment modalities for uveal melanoma.
• Affirmed the unexpectedly low rates of metastasis and death.
• Encouraged continued dialogue within the oncology community.

Abstract